Buprenorphine relaxation of regulations

Back in March 2020 the DEA relaxed regulations for drug testing with Buprenorphine. It allowed for more telemedicine, less in person visits and less testing. Well it's been over a year and I don't see any updates. I've looked at the SAMHSA websites and don't see any. If anything more relaxation occurred. Now I'm getting paranoid that they've made new regulations or restarted prior regulations that I'm not aware. I'm going to give SAMHSA a call this coming Monday. Anyone know of... Read more
Source: Student Doctor Network - Category: Universities & Medical Training Authors: Tags: Psychiatry Source Type: forums